Inventor
Hannah Jörißen
Inventor
Heiligenhaus, DE
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides24%
C07DHeterocyclic compounds10%
PatentTitleYear
11,046,783Antibodies capable of binding to the coagulation factor XIa and uses thereof202110,221,247Antibodies capable of binding to the coagulation factor XIa and uses thereof201910,047,096Substituted pyridobenzodiazepinone-derivatives and use thereof201810,040,866Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof20189,783,614'Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof'20179,394,309'Substituted phenylimidazopyrazoles and their use'20168,992,932'Binder-drug conjugates (ADCs) and use thereof'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015Patents assigned to SEATTLE GENETICS INC (1)· patent assignee history
2015–2016Based in Essen, DE· patent location history
2016–2021Patents assigned to Bayer Pharma AG (6)· patent assignee history
2016Patents assigned to BAYER IP GMBH (1)· patent assignee history
2017–2021Based in Heiligenhaus, DE· patent location history
2018Patents assigned to HEINRICH KELDENICH PETRA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 6 | 2016–2021 |
| BAYER IP GMBH | 1 | 2016 |
| HEINRICH KELDENICH PETRA | 1 | 2018 |
| SEATTLE GENETICS INC | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Heiligenhaus, DE | 5 | 2017–2021 |
| Essen, DE | 2 | 2015–2016 |